— Know what they know.
Not Investment Advice
Also trades as: ALIMP.PA (PAR) · $vol 0M

IMPZY OTC

Implanet S.A.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.2% 3Y: +0.6% 5Y: +0.6%
$0.08
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 42 · $230.1M mcap · 36M float · 0.013% daily turnover

Balance Sheet Trends

Total Assets
$15M +40.0% ▲
5Y CAGR: +9.1%
Total Liabilities
$14M +31.0% ▲
5Y CAGR: +11.5%
Shareholders Equity
$727K +517.8% ▲
5Y CAGR: -12.7%
Cash & Investments
$2M +546.0% ▲
5Y CAGR: +28.9%
Total Debt
$7M +5.7% ▲
5Y CAGR: +9.6%
Net Debt
$5M -17.0% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$1M$2M$531K$248K$2M
Short-Term Investments$128K$0$0$0$0
Cash & ST Investments$1M$2M$531K$248K$2M
Net Receivables$2M$3M$4M$2M$3M
Inventory$4M$3M$3M$4M$6M
Other Current Assets$494K$820K$2M$554K$0
Total Current Assets$7M$9M$8M$6M$10M
Property, Plant & Equip.$792K$1M$1M$1M$2M
Goodwill & Intangibles$837K$7M$7M$3M$3M
Long-Term Investments$25K$827K$23K$0$112K
Other Non-Current Assets$79K$132K$132K$106K$86K
Total Non-Current Assets$2M$8M$6M$4M$5M
Total Assets$9M$17M$14M$11M$15M
— Liabilities —
Accounts Payable$2M$3M$3M$3M$6M
Short-Term Debt$2M$3M$4M$4M$4M
Deferred Revenue$100K$135K$182K$132K$102K
Other Current Liabilities$95K$275K$0$398K$443K
Total Current Liabilities$5M$8M$8M$9M$12M
Long-Term Debt$3M$5M$2M$1M$1M
Other Non-Current Liab.$208K$230K$198K$171K$218K
Total Non-Current Liabilities$3M$6M$3M$2M$2M
Total Liabilities$8M$14M$11M$11M$14M
— Equity —
Common Stock$535K$1M$312K$410K$1M
Retained Earnings-$10M-$6M-$7M-$10M-$8M
Accumulated OCI-$540K-$439K-$348K-$4M-$185K
Total Stockholders Equity$1M$3M$4M-$174K$727K
Total Liabilities & Equity$9M$17M$14M$11M$15M
— Key Metrics —
Total Debt$5M$10M$7M$6M$7M
Net Debt$4M$8M$6M$6M$5M
Total Investments$153K$827K$23K$0$112K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms